Research Notes

Multipurpose Hormone Scientists at Baylor College of Medicine have identified a new role for leptin: potent inhibitor of bone formation acting through the central nervous system (P. Ducy et al., "Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass," Cell, 100:197-207, Jan. 21, 2000). This is the first indication that the brain has a central role in controlling bone formation and density. The researchers worked with two groups of mice; one mutant strain was

Written byNadia Halim
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Multipurpose Hormone

Scientists at Baylor College of Medicine have identified a new role for leptin: potent inhibitor of bone formation acting through the central nervous system (P. Ducy et al., "Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass," Cell, 100:197-207, Jan. 21, 2000). This is the first indication that the brain has a central role in controlling bone formation and density. The researchers worked with two groups of mice; one mutant strain was unable to make leptin, while the other group was unable to make the leptin receptor in the hypothalamus. Experiments showed that disrupting the leptin pathway triggered increased bone formation, so the mice were able to overcome their predisposition for low bone mass because they had no functional gonads. "Two arguments suggest that the function of leptin in bone formation is at least as important as its function in regulating body weight," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies